相关实验视频
Updated: Jun 26, 2025
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
对易受伤害和故障的右心室进行周期性管理
R C Arora1,2, J K Brown3, S Chatterjee4,5
1Harrington Heart and Vascular Institute - University Hospitals, Cleveland, OH, USA. rakeshcarora@gmail.com.
Perioperative medicine (London, England)
|May 15, 2024
概括
识别和管理右心室 (RV) 功能障碍对于降低患者死亡率至关重要. 本综述提出了为及时决策提供评分系统,并详细说明了接受手术的脆弱患者的麻醉管理.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 关键护理医学 关键护理医学
背景情况:
- 右心室 (RV) 功能障碍和衰竭显著增加外科手术期间的发病率和死亡率.
- 低于最佳的RV问题的识别和管理构成了重大的临床挑战.
研究的目的:
- 提出一个共识提出的评分系统,用于早期识别和决策的患者,脆弱的RVs.
- 在手术室和重症监护室详细介绍麻醉管理策略.
- 概述一个升级式方法来管理RV故障,包括机械循环支持.
主要方法:
- 审查当前文献和基于共识的建议.
- 描述一种包含外科背景的新型评分系统.
- 关于麻醉管理,监测和RV失效治疗升级的指导.
主要成果:
- 为快速的患者管理提出了一个务实的评分系统.
- 详细介绍了手术室和ICU的实际麻醉和监测方法.
- 概述了包括机械支持在内的RV故障的升级管理策略.
结论:
- 早期识别和迅速管理RV功能障碍对于改善患者的治疗结果至关重要.
- 拟议的评分系统和管理策略为术后护理提供了一个实际的框架.
- 综合麻醉和重症监护方法对于RV脆弱性的患者至关重要.
更多相关视频
07:27Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
3.1K
相关概念视频
01:29Acute Respiratory Failure-V
135
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
135
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422